LifeMD LFMD
NASDAQ LFMD
$3.08 +0.03 (+0.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020)

LifeMD's (LFMD) quarterly Asset Writedowns and Impairment came in at $74530.0 in Q4 2020, up 1728.72% quarter-over-quarter from -$4576.0 in Q3 2017.

Analysis

LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020) Analysis & Trends

LifeMD (LFMD) has reported Asset Writedowns and Impairment for 3 consecutive years, with $74530.0 the latest figure, recorded in Q4 2020.

  • For the quarter ending Q4 2020, Asset Writedowns and Impairment changed N/A year-over-year to $74530.0; the trailing twelve-month figure through Dec 2021 stood at $74530.0 (up 17.48% YoY), and the FY2024 full-year result was $675669.0, up 25.66% from the prior year.
  • Asset Writedowns and Impairment improved to $74530.0 in Q4 2020 per LFMD's latest filing, from -$4576.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $114694.0 in Q4 2016 and bottomed at -$38027.0 in Q1 2017.
  • Historically, Asset Writedowns and Impairment has averaged $28021.0 across 3 years, with a median of -$4576.0 in 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn
7 Akso Health 259.44 Mn 259.25 Mn -
8 LifeMD 147.29 Mn 147.29 Mn -
9 eHealth 31.71 Mn -69.34 Mn -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 74,530.00
Sep 30, 2017 -4,576.00
Jun 30, 2017 -6,516.00
Mar 31, 2017 -38,027.00
Dec 31, 2016 114,694.00